Oxford Immunotec Global PLC Profit Margin

Oxford Immunotec Global PLC (OXFD) currently reports a profit margin of -30.51% as of September 2020. That compares with 198.51% in the prior-year period — down 115.4% year over year. That is below the Healthcare sector average of 9.48%. Use the charts on this page to explore Oxford Immunotec Global PLC's profit margin history and peer comparisons.

Oxford Immunotec Global PLC's profit margin decreased from 198.51% to -30.51% — a 115.4% year-over-year decrease (period ending September 2020). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Oxford Immunotec Global PLC's profit margin of -30.51% is lower than the Healthcare sector average of 9.48%. That is roughly 421.8% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Oxford Immunotec Global PLC's current -30.51% should be judged against Healthcare norms (sector average: 9.48%) and against OXFD's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -30.51%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 9.48%. From there, open related valuation or income-statement pages for Oxford Immunotec Global PLC, and consider following OXFD for alerts when major investors trade the stock.